- Home
- ACRV vs DHAI Comparison
ACRV vs DHAI Comparison
Compare ACRV & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- DHAI
- Stock Information
- Founded
- ACRV 2018
- DHAI 2007
- Country
- ACRV United States
- DHAI United States
- Employees
- ACRV N/A
- DHAI N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- DHAI
- Sector
- ACRV Health Care
- DHAI
- Exchange
- ACRV Nasdaq
- DHAI NYSE
- Market Cap
- ACRV 59.9M
- DHAI 49.1M
- IPO Year
- ACRV 2022
- DHAI N/A
- Fundamental
- Price
- ACRV $1.16
- DHAI $0.18
- Analyst Decision
- ACRV Strong Buy
- DHAI
- Analyst Count
- ACRV 5
- DHAI 0
- Target Price
- ACRV $19.75
- DHAI N/A
- AVG Volume (30 Days)
- ACRV 1.3M
- DHAI 1.8M
- Earning Date
- ACRV 05-20-2025
- DHAI 02-14-2025
- Dividend Yield
- ACRV N/A
- DHAI N/A
- EPS Growth
- ACRV N/A
- DHAI N/A
- EPS
- ACRV N/A
- DHAI N/A
- Revenue
- ACRV N/A
- DHAI $69,573,000.00
- Revenue This Year
- ACRV N/A
- DHAI N/A
- Revenue Next Year
- ACRV N/A
- DHAI N/A
- P/E Ratio
- ACRV N/A
- DHAI N/A
- Revenue Growth
- ACRV N/A
- DHAI 5.40
- 52 Week Low
- ACRV $1.30
- DHAI $0.12
- 52 Week High
- ACRV $10.29
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- ACRV 28.93
- DHAI 42.74
- Support Level
- ACRV $1.32
- DHAI $0.16
- Resistance Level
- ACRV $1.50
- DHAI $0.20
- Average True Range (ATR)
- ACRV 0.17
- DHAI 0.03
- MACD
- ACRV 0.06
- DHAI 0.01
- Stochastic Oscillator
- ACRV 1.55
- DHAI 27.88
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.